Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32

The Journal of Clinical Investigation
P N AdjeiG J Gores

Abstract

Progress in the treatment of hepatocellular carcinoma (HCC), a common tumor worldwide, has been disappointing. Inhibitors of topoisomerases are being widely studied as potential inducers of tumor cell apoptosis. Our aims were to determine whether topoisomerase-directed drugs would induce apoptosis in a human HCC cell line (Hep 3B) and, if so, to investigate the mechanism. The topoisomerase I poison camptothecin (CPT) induced apoptosis of Hep 3B cells in a time- and concentration-dependent manner. In contrast, the topoisomerase II poison etoposide failed to induce apoptosis despite the apparent stabilization of topoisomerase II-DNA complexes. Unexpectedly, CPT-induced apoptosis in this cell type occurred without any detectable cleavage of poly(ADP-ribose) polymerase or lamin B, polypeptides that are commonly cleaved in other cell types undergoing apoptosis. Likewise, Hep 3B cell apoptosis occurred without a detectable increase in interleukin-1beta-converting enzyme (ICE)-like or cysteine protease P32 (CPP32)-like protease activity. In contrast, trypsin-like protease activity (cleavage of Boc-Val-Leu-Lys-chloromethylaminocoumarin in situ) increased threefold in cells treated with CPT but not etoposide. Tosyl-lysyl chloromethyl ke...Continue Reading

References

Jun 9, 1992·Biochemical Pharmacology·J Y ChangY C Cheng
Apr 3, 1992·Science·D P CerrettiL A Cannizzaro
Dec 1, 1992·Toxicology Letters·R Schulte-HermannA Wagner
May 8, 1992·International Journal of Cancer. Journal International Du Cancer·Y ZouR Perez-Soler
Jun 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·F A OberhammerR Schulte-Hermann
Jul 13, 1988·Biochimica Et Biophysica Acta·D LamarreG G Poirier
Jan 1, 1989·Annual Review of Biochemistry·L F Liu
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M J KosturaJ A Schmidt
Sep 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J BruixL Boix
Sep 15, 1995·The Journal of Biological Chemistry·S J Froelich-Ammon, N Osheroff
May 11, 1995·The New England Journal of Medicine·UNKNOWN Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire
Dec 1, 1994·The Journal of Clinical Investigation·T PatelG J Gores
May 15, 1993·Lancet·D A Carson, J M Ribeiro
Apr 15, 1994·Cancer·J F KerrB V Harmon
Nov 1, 1993·Seminars in Liver Disease·M Colombo
Nov 1, 1995·Current Opinion in Oncology·S W Lowe
Jun 14, 1996·Cell·A Fraser, G Evan
Jun 1, 1996·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·K W Kohn

❮ Previous
Next ❯

Citations

Jun 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R A JonesG E Kass
Apr 1, 1999·Cell Biochemistry and Biophysics·L R RobertsG J Gores
Jul 25, 2003·Toxicology and Applied Pharmacology·Rachel M PattersonDori Germolec
Sep 28, 1998·Biochimica Et Biophysica Acta·S H Kaufmann
Feb 18, 1999·Toxicology Letters·P NicoteraE Ferrando-May
Jan 24, 2007·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Nathalie VadrotGérard Feldmann
Oct 8, 1998·American Journal of Respiratory Cell and Molecular Biology·C BarazzoneP F Piguet
Jan 12, 1999·The Journal of Clinical Investigation·W A FaubionG J Gores
Oct 30, 1999·Biological Chemistry·P NicoteraC Volbracht
Apr 14, 2000·Brain Pathology·P NicoteraC Volbracht
Nov 1, 2007·Neoplasia : an International Journal for Oncology Research·Yide MeiMian Wu
Sep 16, 2008·Toxicology Letters·Cuifen WangLuyong Zhang
Sep 15, 2005·Cancer Letters·Alena VaculováAlois Kozubík
Jan 24, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Valérie BoigeMichel Ducreux
Aug 31, 2000·Annual Review of Biochemistry·A StrasserV M Dixit
Jun 12, 2003·Cell Transplantation·Takakazu MatsushitaScott L Nyberg
Nov 26, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A RibeiroG J Gores
Oct 26, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J ParkT Patel
Mar 30, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J ParkT Patel
May 9, 2000·Cell Death and Differentiation·N Nakamura, Y Wada
Aug 3, 1999·Japanese Journal of Cancer Research : Gann·T OhyamaT Sato
Jan 1, 1997·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·P J Duriez, G M Shah
Nov 23, 2013·The Journal of Biological Chemistry·Haiming DaiScott H Kaufmann
Mar 6, 2003·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Shiho NatoriGregory J Gores
Apr 13, 2004·Oncogene·Pierluigi Nicotera, Gerry Melino
Feb 24, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Joel M ReidMatthew M Ames
Oct 3, 1999·Archives of Pathology & Laboratory Medicine·X ZhangF Kiechle

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis